Clinical Trials Directory

Trials / Conditions / Dermatofibrosarcoma Protuberans

Dermatofibrosarcoma Protuberans

7 registered clinical trials studyying Dermatofibrosarcoma Protuberans.

StatusTrialSponsorPhase
CompletedTreatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger
NCT03381846
Mayo ClinicN/A
CompletedVismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced
NCT01154452
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedCixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta
NCT00720174
National Cancer Institute (NCI)Phase 1
CompletedAZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00659360
National Cancer Institute (NCI)Phase 2
CompletedObservation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft
NCT00346164
Children's Oncology GroupPhase 3
CompletedNeoadjuvant Imatinib in Dermatofibrosarcoma Protuberans
NCT00243191
Sarcoma Alliance for Research through CollaborationPhase 2
CompletedImatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans
NCT00084630
National Cancer Institute (NCI)Phase 2